Total Payments
$7,097
2024 Payments
$812.69
Companies
36
Transactions
491
Medicare Patients
2,630
Medicare Billing
$185,348
Payment Breakdown by Category
Food & Beverage$7,052 (99.4%)
Education$44.78 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,052 | 486 | 99.4% |
| Education | $44.78 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,073 | 81 | $0 (2024) |
| ABBVIE INC. | $795.07 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $750.60 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $639.32 | 55 | $0 (2024) |
| Novo Nordisk Inc | $557.76 | 47 | $0 (2024) |
| PFIZER INC. | $386.78 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $381.10 | 36 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $341.53 | 18 | $0 (2024) |
| Amgen Inc. | $340.41 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $229.47 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $812.69 | 42 | ABBVIE INC. ($188.45) |
| 2023 | $1,025 | 66 | ABBVIE INC. ($260.48) |
| 2022 | $965.67 | 59 | ABBVIE INC. ($254.44) |
| 2021 | $516.98 | 35 | Lilly USA, LLC ($120.31) |
| 2020 | $187.56 | 14 | PFIZER INC. ($30.68) |
| 2019 | $990.04 | 73 | Lilly USA, LLC ($139.40) |
| 2018 | $1,456 | 110 | Novo Nordisk Inc ($199.81) |
| 2017 | $1,143 | 92 | AstraZeneca Pharmaceuticals LP ($165.65) |
All Payment Transactions
491 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: VIROLOGY | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardio-renal | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.16 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Biological | ||||||
| 06/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: DIABETES | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 85 | 173 | $5,394 | $1,154 |
| 2022 | 9 | 479 | 732 | $61,843 | $26,090 |
| 2021 | 18 | 1,010 | 1,534 | $156,526 | $83,954 |
| 2020 | 18 | 1,056 | 1,607 | $165,358 | $74,150 |
Total Patients
2,630
Total Services
4,046
Medicare Billing
$185,348
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 60 | $2,100 | $570.42 | 27.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 48 | 53 | $2,650 | $504.56 | 19.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 49 | $490.00 | $54.80 | 11.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 11 | $154.00 | $24.20 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 175 | $24,325 | $8,269 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 58 | 58 | $8,120 | $7,305 | 90.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 110 | $10,890 | $4,934 | 45.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 24 | 24 | $4,800 | $1,953 | 40.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 12 | 197 | $5,910 | $1,553 | 26.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 59 | 59 | $2,950 | $1,033 | 35.0% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 59 | 77 | $3,850 | $737.43 | 19.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $704.00 | $258.40 | 36.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 20 | 21 | $294.00 | $46.47 | 15.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 265 | 465 | $65,100 | $32,741 | 50.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 62 | 62 | $10,005 | $10,010 | 100.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 119 | 119 | $23,800 | $9,401 | 39.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 106 | 150 | $15,000 | $8,259 | 55.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 64 | 64 | $7,980 | $7,550 | 94.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 65 | 65 | $6,321 | $4,242 | 67.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 13 | 13 | $4,407 | $2,599 | 59.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 21 | 21 | $2,520 | $2,519 | 100.0% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2021 | 15 | 190 | $5,700 | $1,437 | 25.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 72 | 72 | $3,460 | $1,274 | 36.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 71 | 72 | $2,520 | $1,140 | 45.2% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 19 | 19 | $1,710 | $706.99 | 41.3% |
About Dr. David Hartung, DO
Dr. David Hartung, DO is a Family Medicine healthcare provider based in Seymour, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104882711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hartung, DO has received a total of $7,097 in payments from pharmaceutical and medical device companies, with $812.69 received in 2024. These payments were reported across 491 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,052).
As a Medicare-enrolled provider, Hartung has provided services to 2,630 Medicare beneficiaries, totaling 4,046 services with total Medicare billing of $185,348. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Seymour, IN
- Active Since 04/22/2006
- Last Updated 11/14/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1104882711
Products in Payments
- VRAYLAR (Drug) $348.04
- TRULICITY (Drug) $317.96
- EMGALITY (Drug) $287.70
- UBRELVY (Drug) $276.59
- BEVESPI AEROSPHERE (Drug) $254.14
- MOUNJARO (Drug) $239.93
- FARXIGA (Drug) $231.58
- TRELEGY ELLIPTA (Drug) $221.14
- Ozempic (Drug) $216.59
- ANORO (Drug) $197.46
- ENTRESTO (Drug) $168.56
- Victoza (Drug) $166.83
- SYMBICORT (Drug) $154.16
- QULIPTA (Drug) $147.37
- JARDIANCE (Drug) $146.62
- LEQVIO (Drug) $140.55
- XARELTO (Drug) $133.85
- JANUVIA (Drug) $127.75
- ELIQUIS (Drug) $123.61
- Dexcom G6 Transmitter (Medical Supply) $122.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Seymour
Dr. Wesley Payne, M.d, M.D
Family Medicine — Payments: $15,301
Family Medicine $15,301
Garrett Rowe, Md, MD
Family Medicine — Payments: $8,632
Family Medicine $8,632
Dr. Bradley Morin, M.d, M.D
Family Medicine — Payments: $8,001
Family Medicine $8,001
Dr. Nicholas Lemming, Md, MD
Family Medicine — Payments: $7,667
Family Medicine $7,667
Wayne Stuart, Do, DO
Family Medicine — Payments: $7,051
Family Medicine $7,051
Clay Stalcup, Md, MD
Family Medicine — Payments: $5,768
Family Medicine $5,768